99214 CPT Code (2026): Moderate MDM E/M

• CPT Codes
• 99214

99214 CPT Code (2026): Moderate MDM E/M

CPT code 99214 for moderate complexity office visits. Documentation, MDM criteria, and billing guidance for behavioral health.

Quick Reference

Code

99214

Code System

CPT

Category

CPT Codes

Published

Mar 4, 2026

Reading Time

14 min

CPT® is a registered trademark of the American Medical Association. All CPT code descriptions on this page are paraphrased in original wording; consult the current CPT® codebook published by the AMA for authoritative descriptors.

Understanding CPT Code 99214: Moderate Complexity Office Visit

CPT code 99214 is one of the most searched and most frequently billed evaluation and management (E&M) codes in medicine. It describes an office or other outpatient visit for an established patient requiring moderate complexity medical decision making or 30 to 39 minutes of total time. For behavioral health treatment centers, 99214 is the primary code for medication management encounters where providers are actively making clinical decisions about psychiatric medications, evaluating changes in a patient’s condition, and managing moderate clinical risk.

Getting 99214 right matters. It is the second-highest reimbursing established patient E&M code in the outpatient series, and its frequency in behavioral health billing makes it a common target for payer audits. This comprehensive guide covers everything behavioral health billing managers and clinical directors need to know: the MDM criteria, detailed documentation requirements, how to distinguish 99214 from its neighbors, modifier usage, and compliance strategies.

Definition and Purpose

CPT 99214 describes an office or other outpatient visit for the evaluation and management of an established patient, which requires a medically appropriate history and/or examination and moderate complexity medical decision making.

Code selection is based on either:

For 99214, the MDM level is moderate, defined by meeting at least two of the following three elements:

When using time, 99214 requires 30 to 39 minutes of total time on the date of the encounter.

• The level of medical decision making (MDM), or
• Total time spent on the date of the encounter

Why 99214 is central to behavioral health billing

In behavioral health, most substantive clinical encounters involve prescription drug management — initiating, adjusting, or monitoring psychotropic medications. Under the current MDM framework, prescription drug management constitutes moderate risk, which is one of the three MDM elements needed for 99214. This means that any encounter where a provider is actively managing prescription medications and meets at least one additional moderate-level element (problems or data) can be appropriately coded as 99214.

This is why 99214 is the dominant E&M code for psychiatrists, psychiatric nurse practitioners, and other prescribers in behavioral health settings who are doing active medication management.

99213 vs 99214: How to Choose the Right Level

The boundary between 99213 and 99214 is one of the most critical coding distinctions in behavioral health. Choosing the wrong code in either direction creates compliance risk: overcoding 99214 when 99213 is supported can trigger audit recoupment, while undercoding 99213 when 99214 is supported leaves revenue on the table.

Side-by-side comparison

Clinical scenarios that differentiate the two codes

Scenario 1: Stable depression follow-up = 99213 A patient with major depressive disorder has been on sertraline 100mg for six months. PHQ-9 is stable at 5. Patient reports no side effects. Provider continues current regimen, schedules follow-up in three months. This is one stable chronic illness, limited data (reviewed PHQ-9), and low risk (continuing existing medication without changes). This supports 99213.

Scenario 2: Depression with worsening symptoms = 99214 The same patient returns, but PHQ-9 has increased from 5 to 14. The patient reports increased fatigue and loss of interest. The provider reviews the PHQ-9, discusses options with the patient, decides to increase sertraline from 100mg to 150mg, and orders a thyroid panel to rule out a contributing medical cause. This is a chronic illness with mild exacerbation, moderate data (ordered and reviewed testing), and moderate risk (prescription drug management with dose change). This supports 99214.

Scenario 3: Medication initiation for anxiety = 99214 A patient with generalized anxiety disorder who has been in therapy but has not yet tried medication. The provider evaluates the patient’s symptoms (GAD-7 score 16), discusses medication options, and initiates buspirone. This involves a new problem requiring additional workup, moderate data (reviewed validated screening tool, assessed for contraindications), and moderate risk (initiating prescription drug management). This supports 99214.

Scenario 4: Medication check, no changes = 99213 A patient on buprenorphine for opioid use disorder. Urine drug screen is consistent with prescribed medication and negative for other substances. Patient is doing well in the program. Provider continues current dose, reviews treatment plan adherence, schedules next follow-up. One stable chronic illness, limited data review, low risk. This supports 99213.

The prescription drug management rule

Many behavioral health providers assume that any visit involving a prescription medication automatically qualifies for 99214. This is a common misconception. Prescription drug management at the moderate risk level requires the provider to be actively making decisions about medications — initiating, adjusting, or monitoring for side effects or interactions. Simply continuing an existing medication in a stable patient does not, by itself, constitute moderate-risk prescription drug management. The risk element is about the decision making, not the mere existence of a prescription.

Time-Based vs MDM-Based Selection

Providers can select 99214 using either MDM or total time. Understanding when to use each approach is important for accurate coding.

MDM-based selection (most common)

Most behavioral health encounters that support 99214 are best documented using MDM criteria because the clinical reasoning is the core of the visit. MDM-based selection requires meeting two of three elements at the moderate level.

Advantages:

When to use MDM:

• Directly reflects clinical complexity
• Easier to defend in audits because it maps to clinical reasoning
• Does not require precise time tracking

• Standard medication management visits with active clinical decisions
• Follow-ups where the complexity of the encounter is the driving factor
• Encounters where exact time may be hard to document precisely

Time-based selection

Time-based selection is valid when the provider spends 30-39 minutes of total time on the date of the encounter.

Advantages:

When to use time:

Documentation requirement for time-based selection:

• Useful for encounters that consume significant time but may not clearly meet two MDM elements at moderate level
• Accounts for non-face-to-face work (chart review, care coordination, documentation)

• Extended counseling sessions combined with E&M
• Encounters involving extensive care coordination or record review
• Situations where the time spent clearly supports 99214 even if MDM documentation is borderline

• State the total time (e.g., “Total time on date of encounter: 35 minutes”)
• Describe how the time was spent (e.g., “15 minutes face-to-face evaluation, 10 minutes reviewing records and lab results, 5 minutes care coordination with therapist, 5 minutes documentation”)

When NOT to use time

Do not use time-based selection to justify a higher code level when MDM does not support it and the time spent was primarily on activities that do not represent clinical complexity. For example, spending 35 minutes on a straightforward stable medication refill because the provider was running behind schedule does not justify 99214 on a time basis — the time must reflect medically necessary activities for the encounter.

Documentation Requirements

The three MDM elements in detail

To bill 99214, the documentation must clearly demonstrate at least two of three MDM elements at the moderate level.

Element 1: Number and complexity of problems addressed

Document each problem evaluated during the encounter with clinical specificity. Generic descriptions like “depression follow-up” are insufficient. Instead:

The key is to communicate the complexity of the problems, not just their existence.

• “Major depressive disorder, recurrent, moderate, with mild exacerbation — PHQ-9 increased from 8 to 14 over past month”
• “ Alcohol use disorder, moderate, stable on naltrexone 50mg daily; co-occurring generalized anxiety disorder with new onset insomnia”
• “Undiagnosed new-onset tremor, uncertain etiology — could be medication side effect vs. essential tremor”

Element 2: Amount and complexity of data reviewed and analyzed

Document specific data sources with your clinical analysis:

Each of these represents a category of data that contributes to the moderate data threshold.

• Tests ordered and reviewed: “Ordered TSH and CBC. Reviewed results: TSH 2.1 (normal), CBC within normal limits. No medical explanation for worsening mood symptoms.”
• Prior external records: “Reviewed emergency department records from Community Hospital dated 2/20/2026 documenting patient’s visit for chest pain, negative cardiac workup. Anxiety likely contributing to somatic symptoms.”
• History from someone other than patient: “Discussed patient’s recent behavior with spouse (with patient’s consent). Spouse reports increased irritability and social withdrawal over past two weeks.”
• Independent interpretation: “Reviewed urine drug screen results. Independently interpreted findings: positive for prescribed buprenorphine metabolites, negative for all other substances.”
• Discussion with external physician: “Called Dr. Smith (PCP) to discuss coordination of gabapentin for anxiety vs. neuropathic pain. Agreed to continue gabapentin at current dose with behavioral health managing the anxiety indication.”

Element 3: Risk of complications, morbidity, or mortality

For behavioral health, the most common moderate-risk element is prescription drug management. Document it explicitly:

Document the specific drug decisions, the risks considered, and the monitoring plan. This is what distinguishes moderate risk from low risk.

• “Increasing sertraline from 100mg to 150mg. Discussed potential for increased side effects during titration, including serotonin syndrome risk in combination with trazodone. Monitoring plan in place.”
• “Initiating lithium 300mg BID. Reviewed risks of lithium toxicity. Ordered baseline BMP, TSH, and lithium level. Patient counseled on hydration, sodium intake, and signs of toxicity.”
• “Switching from paroxetine to escitalopram due to weight gain. Discussed cross-taper schedule to minimize discontinuation symptoms. Risk of serotonin syndrome during overlap period reviewed.”

Complete documentation template structure

A well-documented 99214 encounter in behavioral health typically follows this structure:

• Chief complaint / Reason for visit
• History of present illness — Current symptoms, medication effects, changes since last visit
• Review of relevant data — Lab results, screening tools, external records reviewed
• Mental status examination — At minimum: appearance, behavior, mood, affect, thought process, judgment/insight
• Assessment — Each active problem with current status (stable, improved, worsened, exacerbated)
• Plan — Specific interventions for each problem, medication changes with rationale, follow-up schedule, safety planning if applicable

Billing and Reimbursement

Medicare reimbursement

As of March 2026, the approximate Medicare national average reimbursement for CPT 99214 is around $143 in the non-facility (office) setting.

Geographic locality adjustments (GPCIs) may shift rates by 10-20% depending on the region.

Commercial and Medicaid reimbursement

Commercial insurance rates for 99214 typically range from $160 to $220, varying by payer contract, geographic location, and provider specialty. Medicaid rates vary significantly by state but are often comparable to Medicare or slightly lower.

Billing with add-on psychotherapy codes

The 99214 + psychotherapy add-on combination is one of the most common billing patterns in outpatient psychiatry:

When billing 99214 with an add-on psychotherapy code:

• Document the E&M service and psychotherapy component separately
• Do not use modifier 25 (add-on psychotherapy codes are designed to be billed with E&M codes)
• Allocate time between E&M and psychotherapy activities
• Ensure each service meets its independent requirements

Volume benchmarks

In behavioral health, 99214 typically represents 25-40% of established patient E&M volume for prescribers. This percentage is higher than in many other specialties because of the prevalence of prescription drug management in psychiatry. However, if 99214 consistently exceeds 50% of a provider’s established patient E&M volume, a coding review is warranted to ensure documentation supports every claim.

Common Modifiers

• Modifier 25 — Significant, separately identifiable E&M service on the same day as a procedure (not used with psychotherapy add-on codes). Required when billing 99214 alongside a separately reported procedure.
• Modifier 95 — Synchronous telemedicine service. Use when the 99214 visit is conducted via real-time audio-video telehealth. Behavioral health has high telehealth utilization, making this modifier very common.
• Modifier 59 — Distinct procedural service. Rarely used with E&M codes but may apply in specific scenarios.
• Modifier 76 — Repeat procedure by same physician. Uncommon for E&M but may apply in certain same-day scenarios.
• Modifier AI — Principal physician of record in facility settings.

Telehealth modifier guidance

For behavioral health providers delivering 99214 via telehealth:

• Append modifier 95 (or use POS 02/10 depending on payer requirements)
• Document that the encounter was conducted via synchronous audio-video technology
• All MDM or time requirements apply identically to telehealth encounters
• Verify payer-specific telehealth policies, as requirements vary

Compliance Considerations

Audit risk profile

CPT 99214 carries high audit risk due to its frequency and the revenue difference between it and 99213 (~$46 per claim). Common audit scenarios include:

• Payer-initiated audits: Insurance companies routinely audit providers whose 99214 utilization exceeds peer benchmarks for their specialty
• OIG audits: The Office of Inspector General has historically targeted E&M coding accuracy, with 99214 overuse identified as a persistent concern
• RAC audits: Recovery Audit Contractors review Medicare claims and may request documentation for 99214 encounters

Most common audit findings

• Downcoded to 99213. The most frequent audit outcome is that documentation supports low complexity (99213) rather than moderate complexity (99214). This typically happens when: Only one MDM element meets the moderate threshold instead of two
• The note documents stable medication continuation without active drug management decisions
• Data review is mentioned but not documented with specificity
• Missing risk documentation. The provider manages medications but does not document the risk assessment associated with those decisions. Stating “continue Lexapro 20mg” without discussing the clinical reasoning does not clearly establish moderate risk.
• Insufficient problem documentation. The note does not specify the complexity or acuity of the problems addressed. “Anxiety f/u” does not demonstrate the same level of complexity as “Generalized anxiety disorder with mild exacerbation, new onset panic symptoms, GAD-7 increased from 7 to 15.”
• Cloned or templated notes. Notes that are substantially similar across multiple encounters suggest that documentation is not encounter-specific.

Best practices for compliance

• Audit proactively. Review a random sample of 99214 claims monthly or quarterly. Compare documentation to the moderate MDM table element by element.
• Train providers on the 99213/99214 boundary. This is the single most impactful coding education investment for a behavioral health organization.
• Use the MDM table as a checklist. During or after each encounter, the provider should mentally (or literally) check off which MDM elements were met and at what level.
• Document prescription drug management explicitly. Do not assume that the existence of a prescription in the chart establishes moderate risk. The note must reflect active decision making about the medication.
• Differentiate continuing vs. changing medications. Continuing a stable medication is generally low risk. Initiating, adjusting, or monitoring a medication for side effects or interactions is moderate risk.
• Benchmark against specialty norms. Compare your practice’s E&M distribution (percentage of claims at each level from 99211-99215) against published benchmarks for psychiatry and behavioral health.
• Respond to audit requests promptly. If a payer requests documentation for 99214 claims, provide complete records and respond within the required timeframe to avoid automatic recoupment.

Related Billing Codes

• 99211
• 99212
• 99213
• 99215
• 99354
• 99355

Reference tables

Common questions

Official sources

No publisher link is recorded for this topic yet. Confirm the requirement with the governing payer, state agency or accreditor before relying on it — see the primary source directory.